ENGAGE Myeloproliferative Neoplasms
November 2021
The concept of shared decision making is revolutionizing the way patients engage with their healthcare team, improving outcomes by encouraging them to play a more active role in their care. ENGAGE program provides tools and actions for shared decision making and tips for navigating MPN treatment decisions.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding Myeloproliferative Neoplasms
Will Your MPN Progress? What You Need to Know.
November 18, 2021
How to Partner With Your Doctor on Treatment Decisions
November 18, 2021
Expert Advice for Learning About Your MPNs Online
June 25, 2021
How to Engage in Your MPN Treatment Decisions
June 25, 2021
Who Is on Your MPN Healthcare Team?
June 25, 2021
How to Make an Informed MPN Treatment Decision
June 24, 2021
Primary vs. Secondary Myelofibrosis: What’s the Difference?
March 24, 2021
Myeloproliferative Neoplasms Treatment Options
Tips for Discussing MPN Clinical Trials With Your Doctor
November 18, 2021
Promising Research and Treatment Updates From an MPN Expert
November 18, 2021
Why You Should Understand Your MPN Treatment Plan
November 18, 2021
Engage MPNs Resource Guide
November 15, 2021
How Is MPN Treatment Effectiveness Monitored?
June 25, 2021
MPN Treatment: What Is the Role of Biomarkers?
June 25, 2021
What Are the Goals of ET, PV, and MF Treatment?
June 25, 2021
ENGAGE MPNs is brought to you by the Patient Empowerment Network. It is made possible through support from Bristol Myers Squibb, Incyte Corporation and generous donations from people like you.